Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia.
Akkari YMN, Bruyere H, Hagelstrom RT, Kanagal-Shamanna R, Liu J, Luo M, Mikhail FM, Pitel BA, Raca G, Shago M, Shao L, Smith LR, Smolarek TA, Yenamandra A, Baughn LB. Akkari YMN, et al. Among authors: bruyere h. Cancer Genet. 2020 May;243:52-72. doi: 10.1016/j.cancergen.2020.03.001. Epub 2020 Mar 21. Cancer Genet. 2020. PMID: 32302940 Review.
Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.
Gerrie AS, Huang SJ, Bruyere H, Dalal C, Hrynchak M, Karsan A, Ramadan KM, Smith AC, Tyson C, Toze CL, Gillan TL. Gerrie AS, et al. Among authors: bruyere h. Cancer Genet. 2014 Jul-Aug;207(7-8):316-25. doi: 10.1016/j.cancergen.2014.08.006. Epub 2014 Aug 29. Cancer Genet. 2014. PMID: 25441686
Clonal evolution as detected by interphase fluorescence in situ hybridization is associated with worse overall survival in a population-based analysis of patients with chronic lymphocytic leukemia in British Columbia, Canada.
Huang SJ, Bergin K, Smith AC, Gerrie AS, Bruyere H, Dalal CB, Sugioka DK, Hrynchak M, Ramadan KM, Karsan A, Gillan TL, Toze CL. Huang SJ, et al. Among authors: bruyere h. Cancer Genet. 2017 Jan;210:1-8. doi: 10.1016/j.cancergen.2016.10.006. Epub 2016 Nov 3. Cancer Genet. 2017. PMID: 28212806
Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signals.
Abou Mourad YR, Bhargava R, Bruyère H, Gillian T, Barnett MJ, Forrest DL, Nevill TJ, Toze CL, Nantel SH, Shepherd JD. Abou Mourad YR, et al. Among authors: bruyere h. Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):281-6. doi: 10.1016/j.clml.2012.09.007. Epub 2012 Oct 24. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23098889
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.
Lin Y, Bruyère H, Horsman DE, Pantzar T, Barnett MJ, Hogge DE, Nevill TJ, Nantel SH, Sutherland HJ, Toze CL, Shepherd JD, Lavoie JC, Song KW, Smith CA, Forrest DL. Lin Y, et al. Among authors: bruyere h. Cancer Genet Cytogenet. 2006 Oct 1;170(1):16-23. doi: 10.1016/j.cancergencyto.2006.04.012. Cancer Genet Cytogenet. 2006. PMID: 16965950
Recurrent trisomy 21: four cases in three generations.
Gair JL, Arbour L, Rupps R, Jiang R, Bruyère H, Robinson WP. Gair JL, et al. Among authors: bruyere h. Clin Genet. 2005 Nov;68(5):430-5. doi: 10.1111/j.1399-0004.2005.00512.x. Clin Genet. 2005. PMID: 16207210
Molecular cytogenetics in reproductive pathology.
Bruyère H, Rajcan-Separovic E, Kalousek DK. Bruyère H, et al. Methods Mol Biol. 2002;204:299-307. doi: 10.1385/1-59259-300-3:299. Methods Mol Biol. 2002. PMID: 12397806
85 results